Anti-gH [YC15]
AB00925-10.3-BT
ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry, Neutralisation/Blocking
Product group Antibodies
ReactivityVirus
TargetORF22
Overview
- SupplierAbsolute Antibody
- Product NameAnti-gH [YC15]
- Delivery Days Customer9
- Antibody SpecificityYC15 was shown to bind ectopically-expressed gH on transfected cell lines, as well as neutralise infection by KSHV virions (unpublished observations). Kaposis sarcoma is a rare type of cancer, characterised by neoplasmic growth, often associated with AIDS
- Application Supplier NoteThe YC15 variable domain sequences were cloned and redesigned into the scFv format (Cai & Berger, 2011), and further fused to PE38, a construct of Pseudomonas aeruginosa exotoxin A which is lacking the N-terminal cell adhesion domain. In this format, YC15 showed specific dose-dependent binding to surface-expressed gH using flow cytometry. As an immunotoxin with the fused P. aeruginosa PE38 construct, YC15 facilitated potent cytotoxic activity based on recognition of surface gH epitopes.
- ApplicationsFlow Cytometry, Western Blot, ImmunoHistoChemistry, Neutralisation/Blocking
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDYC15
- Gene ID4961506
- Target nameORF22
- Target descriptionORF22
- Target synonymsHHV8GK18_gp26; ORF22
- HostHuman
- IsotypeIgG1
- Protein IDF5HAK9
- Protein NameEnvelope glycoprotein H
- Scientific DescriptionThis chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityVirus
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203